--Zevra Therapeutics, Inc., a rare disease therapeutics company, today announced that Neil F. McFarlane, Zevra’ s President and Chief Executive Officer, has issued a Letter to Stockholders providing a ...
PLYMOUTH MEETING, Pa., Jan. 9, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from ...
2025 milestones reinforce EagleNXT’s growing role in global aerial intelligence markets and establish a strong foundation for scale in 2026 WICHITA, Kan., Dec. 16, 2025 (GLOBE NEWSWIRE) -- AgEagle ...
Brazil Potash Corp. has made significant progress in 2025 toward its Autazes Potash Project, which aims to alleviate Brazil's heavy dependency on imported potash fertilizer. Key achievements include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results